A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's Disease
Clinical trial NCT06602258 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06602258
- Sponsor
- Eisai Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-30
- Primary completion
- 2026-12-03
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.